Oryzon Diagnosis, SL
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Oryzon Diagnosis, SL - overview
Established
2013
Location
Barcelona, -, Spain
Primary Industry
Healthcare
About
Founded in 2013 and based in Barcelona, Spain, Oryzon Diagnosis, SL provides diagnostics services which comprises development of diagnostic tests for cancer.
Current Investors
Inveready Asset Management, Reig Jofre
Primary Industry
Healthcare
Sub Industries
Diagnostic, Medical & Imaging Laboratories
Website
www.oryzondx.com
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Oryzon Diagnosis, SL - financials
| Fiscal Year Ended | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 14,705.5 | - | 55,000 | - | - | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - | - | - | - |
| EBITDA (USD) | (9,818) | 910,898.1 | (82,166.8) | (102,285.2) | 202,962.3 | 15,091.3 | - | - | - |
| Operating Income (USD) | (9,849.8) | 910,694.4 | (288,784.7) | (337,263.4) | (28,269.9) | (317.9) | - | - | - |
| Operating Margin | (67.0%) | - | (525.1%) | - | - | - | - | - | - |
| % EBITDA Margin | (66.8%) | - | (149.4%) | - | - | - | - | - | - |
| NET Income (USD) | 33,433.2 | 910,694.4 | (216,588.6) | (245,670.6) | (40,566.1) | (7,508.1) | - | - | - |
| % Net Margin | 227.4% | - | (393.8%) | - | - | - | - | - | - |
Oryzon Diagnosis, SL - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Geadic Biotech | - | ||||||||
| Buyout | Completed | Oryzon Diagnosis, SL | - |
Displaying 1 - 2 of 2
Oryzon Diagnosis, SL - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.